Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis
The rate of serious cardiovascular events among participants receiving maintenance hemodialysis was lower with daily supplementation with n-3 fatty acids than with placebo. (Supported by the Heart and Stroke Foundation of Canada and others; PISCES ClinicalTrials.gov number, ISRCTN00691795.).
Authors
- Marcello Tonelli (ORCID: https://orcid.org/0000-0002-0846-3187)
- Paul Tam (ORCID: https://orcid.org/0000-0002-4905-1197)
- Michael E. Farkouh (ORCID: https://orcid.org/0000-0002-8095-0246)
- George Tomlinson (ORCID: https://orcid.org/0000-0002-9328-6399)
- Louise Moist (ORCID: https://orcid.org/0000-0003-3875-9197)
- Brenda R. Hemmelgarn (ORCID: https://orcid.org/0000-0001-6818-4385)
- Kevan R. Polkinghorne
- Charmaine E. Lok
- Jacob A. Udell
Institutions
- Western University (CA)
- University Health Network (CA)
- University of Alberta (CA)
- University of Calgary (CA)
- University of Toronto (CA)
- Scarborough Health Network (CA)
- Women's College Hospital (CA)
- Toronto General Hospital (CA)
- Monash Health (AU)
- Cedars-Sinai Smidt Heart Institute (US)
- Toronto General Hospital Research Institute
- Monash University (AU)
Publication Details
- Journal
- New England Journal of Medicine
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1056/nejmoa2513032
- Citations
- 9
- Primary Topic
- Dialysis and Renal Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 12.88